Search results
Aldeyra Therapeutics has 59,414,490 shares outstanding. What happened to Aldeyra Therapeutics’s price movement after its last earnings report? Aldeyra Therapeutics reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.111. Following the earnings report the stock price went up 0.238%.
Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ...
ALDX stock has risen by 5.91% compared to the previous week, the month change is a 0.51% fall, over the last year Aldeyra Therapeutics, Inc. has showed a 60.16 ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
www.aldeyra.com. Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally ...
May 14, 2024 · A high-level overview of Aldeyra Therapeutics, Inc. (ALDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
52 Week Low Date 10/16/23. Market Cap 234.093M. Shares Out 59.41M. 10 Day Average Volume 0.32M. Dividend -. Dividend Yield -. Beta 1.39. YTD % Change 12.25.
